Do you want to read an article? Please log in or register.
OFEV® extended indication offers new hope for patients with SSc-ILD
Interstitial Lung Disease
SPECIAL REPORT
Related content
PHARMA NEWS
Interstitial Lung Disease
Phase III study showed nintedanib slows the loss of pulmonary function in people living with systemic sclerosis associated ILD1
doi: 10.1056/NEJMoa1903076
RECOMMENDED
Asthma
NSAID-ERD Syndrome: the New Hope from Prevention, Early Diagnosis, and New Therapeutic Targets
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Curr Allergy Asthma Rep.
Laidlaw TM, Levy JM
doi: 10.1007/s11882-020-00905-9.
RECOMMENDED
Pulmonary Hypertension
Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Ann Rheum Dis.
Xanthouli P, Jordan S, Milde N, Marra A, Blank N, Egenlauf B, Gorenflo M, Harutyunova S, Lorenz HM, Nagel C, Theobald V, Lichtblau M, Berlier C, Ulrich S, Grünig E, Benjamin N, Distler O
doi: 10.1136/annrheumdis-2019-216476.Visit the original publication at ncbi.nlm.nih.gov
RECOMMENDED
COPD
Pain in patients with chronic obstructive pulmonary disease indicated for post-acute pulmonary rehabilitation
Chron Respir Dis.
van Dam van Isselt EF, Groenewegen-Sipkema KH, van Eijk M, Chavannes NH, Achterberg WP
doi: 10.1177/1479972318809456.
COPD
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study
Lancet Respir Med.
Gedebjerg A, Szépligeti SK, Wackerhausen LH, Horváth-Puhó E, Dahl R, Hansen JG, Sørensen HT, Nørgaard M, Lange P, Thomsen RW2
doi: 10.1016/
RECOMMENDED
Further Publications
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Highland KB, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, Denton CP, Distler JHW, Hoffmann-Vold AM, Khanna D, Mayes MD, Raghu G, Vonk MC, Gahlemann M, Clerisme-Beaty E, Girard M, Stowasser S, Zoz D, Maher TM, SENSCIS trial investigators.
doi: 10.1016/S2213-2600(20)30330-1
RECOMMENDED
COPD
Characteristics and Outcomes of Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Australia and New Zealand
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Ann Am Thorac Soc.
Berenyi F, Steinfort DP, Ali Abdelhamid Y, Bailey MJ, Pilcher DV, Bellomo R, Finnis ME, Young PJ, Deane AM
doi: 10.1513/AnnalsATS.201911-821OC.
RECOMMENDED
Respiratory Tract Infection
Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series
★ 2
Recommended by
Dr Martin Frey, Faculty Member
BMJ.
Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG, Chang BP, Chau KH, Choi JJ, Gavin N, Goyal P, Mills AM, Patel AA, Romney MS, Safford MM, Schluger NW, Sengupta S, Sobieszczyk ME, Zucker JE, Asadourian PA, Bell FM, Boyd R, Cohen MF, Colquhoun MI, Colville LA, de Jonge JH, Dershowitz LB, Dey SA, Eiseman KA, Girvin ZP, Goni DT, Harb AA, Herzik N, Householder S, Karaaslan LE, Lee H, Lieberman E, Ling A, Lu R, Shou AY, Sisti AC, Snow ZE, Sperring CP, Xiong Y, Zhou HW, Natarajan K, Hripcsak G, Chen R
doi: 10.1136/bmj.m1996.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir Rev
Kalluri M, Luppi F, Vancheri A, Vancheri C, Balestro E, Varone F, Mogulkoc N, Cacopardo G, Bargagli E, Renzoni E, Torrisi S, Calvello M, Libra A, Pavone M, Bonella F, Cottin V, Valenzuela C, Wijsenbeek M, Bendstrup E, 3rd International Summit for ILD (ISILD), Erice collaborators listed below.
doi: 10.1183/16000617.0026-2021